Literature DB >> 6414834

Effects of thiol protease inhibitors on intracellular degradation of exogenous beta-galactosidase in cultured human skin fibroblasts.

Y M Ko, T Yamanaka, M Umeda, Y Suzuki.   

Abstract

The effects of low molecular weight (LMW) protease inhibitors of microbial origin were evaluated on the intracellular degradation of beta-galactosidase purified from Aspergillus oryzae and taken up by cultured human skin fibroblasts with beta-galactosidase deficiency. Only thiol protease inhibitors showed an effect to increase the enzyme activity. E-64, a specific inhibitor of thiol proteases, prolonged 3-fold a half life of the exogenous beta-galactosidase and when the enzyme was supplied as liposomes, the half life was prolonged 9-fold in these cells. The role of thiol proteases in the degradation of enzyme molecules was discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414834     DOI: 10.1016/0014-4827(83)90175-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Protease inhibitors suppress the degradation of mutant adrenoleukodystrophy proteins but do not correct impairment of very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.

Authors:  T Yamada; N Shinnoh; T Kobayashi
Journal:  Neurochem Res       Date:  1997-03       Impact factor: 3.996

2.  Binary gene induction and protein expression in individual cells.

Authors:  Qiang Zhang; Melvin E Andersen; Rory B Conolly
Journal:  Theor Biol Med Model       Date:  2006-04-05       Impact factor: 2.432

3.  Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.

Authors:  Yoshiyuki Suzuki; Seiichiro Ogawa; Yasubumi Sakakibara
Journal:  Perspect Medicin Chem       Date:  2009-05-26

Review 4.  Emerging novel concept of chaperone therapies for protein misfolding diseases.

Authors:  Yoshiyuki Suzuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2014       Impact factor: 3.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.